Recent Updates
Recently added Catalysts
RLAY Neutral Sentiment

Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024

Thursday, February 15, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Relay Therapeutics, a clinical-stage precision medicine firm, has scheduled the announcement of its fourth quarter and full year 2023 financial results and corporate highlights for February 22, 2024. This update will be released after the close of U.S. financial markets. The company is noted for its advanced use of computational and experimental technologies in the drug discovery process, which aims to transform this sector.
Price reaction · baseline $9.89 (2024-02-14 close) · hit after-hours · clean, no other RLAY news in the window
day 0 close
+7.9%
day 1 · peak
+9.6%
day 3
+6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Relay Therapeutics is set to share important financial results.
  • The company is recognized for its innovative approach to drug discovery.
  • The announcement indicates an ongoing transparency with stakeholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+284%
120-day peak, hindsight
Typical move
11.8%
average across 6 past catalysts
Cash runway
~50 mo
Minimal dilution risk
Lead asset
RLY-8161
Phase 1 · Advanced NRAS-Mutant Melanoma

Full Press Release Details

CAMBRIDGE, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report fourth quarter and full year 2023 financial results and corporate highlights after the U.S. financial markets close on Thursday, February 22, 2024.
About Relay Therapeutics

Frequently Asked Questions

When will Relay Therapeutics report its financial results?

Relay Therapeutics plans to report its financial results on February 22, 2024.

What is Relay Therapeutics known for?

Relay Therapeutics specializes in precision medicine and innovative drug discovery.

What stock exchange is Relay Therapeutics listed on?

Relay Therapeutics is listed on Nasdaq under the ticker RLAY.

Where is Relay Therapeutics based?

Relay Therapeutics is based in Cambridge, Massachusetts.

ShareAdd on Google
Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics financial results fourth quarter precision medicine drug discovery
Last updated: Feb 15, 2024

Biotech snapshot

Cash runway
$911M liquidity · $18M/mo burn
~50 mo
Minimal dilution risk
Lead asset
RLY-8161Phase 1
Advanced NRAS-Mutant Melanoma →

Catalyst track record

+284%
best trade around RLAY's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for RLAY.

See every catalyst's timing & PoA →